Abstract:Aims: We have recently identified a functional pool of intracellular β 1 adrenergic receptors (β 1 ARs) crucial for cardiac function. However, the systematic signaling network of intracellular β 1 ARs remains elusive. Here, we aim to uncover the integrative control of cardiac function, compartmentalized β 1 AR signaling, and potential interface between two critical modulators of catecholamine homeostasis, MAO-A and OCT3. Methods and Results: Cardiac deletion of MAO-A (MAO-A-CKO) elevated myocardium catecholamines, cAMP levels and cardiac ejection fraction by disrupting intracellular catecholamine degradation. Deletion and pharmacological inhibition of MAO-A both enhanced cardiac adrenergic response, with elevated ejection fraction and heart rate. Inhibiting OCT3 by corticosterone prevented the impacts of MAO-A inhibition on cardiac function. Using subcellular anchored Förster resonance energy transfer (FRET) biosensors, we then determined the regulation of compartmentalized β 1 AR/PKA signaling at the sarcoplasmic reticulum (SR) and plasma membrane (PM) microdomains. We also examined local PKA-substrates phosphorylation and myocyte excitation-contraction coupling. MAO-A deletion and inhibitor (MAOi) enhanced local PKA activity at the SR, phosphorylation of phospholamban, Ca 2+ cycling, and contractile response. Whereas overexpression of MAO-A impairs SR-localized PKA activity and phospholamban phosphorylation. In contrast, these modifying of MAO-A did not affect PKA activity at PM and L-type Ca 2+ channel phosphorylation. Inhibiting OCT3 blocked blocking catecholamine transport and diminished the efficacy of MAO-A inhibitor (MAO-A) and MAO-A-CKO to regulate SR-localized β 1 AR signaling. In parallel, OCT3 inhibition and deletion prevented the MAO-A-dependent enhancement of Ca 2+ cycling and cardiac contractile function. Conclusion: Together, we show that MAO-A and OCT3 act in a concert to fine-tune the intracellular catecholamines, activation of SR-localized β 1 AR-PKA signaling, and cardiac fight-or-flight response. Further, we reveal a drug contraindication between anti-inflammatory corticosterone and anti-depressant MAOi in modulating adrenergic regulation in the heart, providing novel perspectives of those drugs in cardiac implications.

Ca2+-stimulated adenylyl cyclases as therapeutic targets for psychiatric and neurodevelopmental disorders

Adenylate Cyclase 1 Promotes Strengthening and Experience-Dependent Plasticity of Whisker Relay Synapses in the Thalamus

CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders

Adenylyl cyclase 2 expression and function in neurological diseases

The neurodevelopmental role of dopaminergic signaling in neurological disorders

cAMP-PKA signaling pathway and anxiety: Where do we go next?

Dopaminergic Signaling is Linked to Neurodevelopmental Deficits in Autism Spectrum Disorder (ASD)

PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy

Research advances on CaMKs-mediated neurodevelopmental injury

Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders

Association of adenylate cyclase-2 gene polymorphism with bipolar disorder

A Pattern to Link Adenosine Signaling, Circadian System, and Potential Final Common Pathway in the Pathogenesis of Major Depressive Disorder

A bipolar disorder-associated missense variant alters adenylyl cyclase 2 activity and promotes mania-like behavior

BDNF signaling in context: From synaptic regulation to psychiatric disorders

Abstract P1066: Monoamine Oxidase A And Organic Cation Transporter 3 Coordinate Intracellular Adrenergic Signaling To Calibrate Cardiac Function

Transcranial alternating current stimulation for the treatment of major depressive disorder: from basic mechanisms toward clinical applications

Targeting the circadian modulation: novel therapeutic approaches in the management of ASD

Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications

TAAR1 as an emerging target for the treatment of psychiatric disorders

The involvement of K+ channels in depression and pharmacological effects of antidepressants on these channels